|
|
||||||||
AJP - Heart and Circulatory Physiology, Vol 257, Issue 3 979-H987, Copyright © 1989 by American Physiological Society
ARTICLES |
J. J. Mercadier, J. L. Samuel, J. B. Michel, M. A. Zongazo, D. de la Bastie, A. M. Lompre, C. Wisnewsky, L. Rappaport, B. Levy and K. Schwartz
Institut National de la Sante et de la Recherche Medicale, Hopital Pitie-Salpetriere, Paris, France.
Activation of atrial natriuretic factor (ANF) gene expression has been reported in the rat ventricle in several models of hemodynamic overload, including hypertension. However, nothing is known about the potential trigger(s) and the time course of this activation during the development of hypertension. We measured aortic blood pressure, left ventricular hypertrophy (LVH), and left ventricular ANF mRNA concentration (LV ANF mRNA) in a first group of rats (study A) killed at 5 and 18 h and 2, 4, 6, 9, 15, and 30 days after suprarenal coarctation of the abdominal aorta. Coarctation induced a progressive rise in aortic blood pressure and left ventricular mass. We observed a biphasic accumulation of ANF mRNA in the left ventricle with a peak at day 4 averaging 20 times the control value long before stable hypertension and hypertrophy were achieved, followed by a decrease until day 9. This decrease was followed by a new rise, which stabilized around 10 times the control value seen during stable hypertension and hypertrophy. In a second group of rats killed at days 4 and 30 (study B), we determined, in addition to the previous parameters, left ventricular end-diastolic pressure (LVEDP), plasma renin (PRC), and plasma ANF concentrations. LVEDP and PRC were markedly increased at day 4, but at day 30, during stable hypertension and hypertrophy, these parameters returned to control values, whereas plasma ANF was increased. Using immunocytochemistry, we looked in a third group of rats (study C) for the presence of the immunoreactive peptide at days 4 and 30.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
T. Yamamoto, T. Shirayama, T. Sakatani, T. Takahashi, H. Tanaka, T. Takamatsu, K. W. Spitzer, and H. Matsubara Enhanced activity of ventricular Na+-HCO3 cotransport in pressure overload hypertrophy Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1254 - H1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, N. H. Purcell, A. Lin, and S. Sen Activation of nuclear factor-{kappa}B is necessary for myotrophin-induced cardiac hypertrophy J. Cell Biol., December 10, 2002; (2002) 200207149. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Z. Kim, K. W. Cho, and S. H. Kim Modulation of endocardial natriuretic peptide receptors in right ventricular hypertrophy Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2280 - H2289. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ehmke, J. Faulhaber, K. Munter, M. Kirchengast, and R. J. Wiesner Chronic ETA Receptor Blockade Attenuates Cardiac Hypertrophy Independently of Blood Pressure Effects in Renovascular Hypertensive Rats Hypertension, April 1, 1999; 33(4): 954 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tanaka, T. Ryoke, M. Hongo, L. Mao, H. A. Rockman, R. G. Clark, and J. Ross Jr. Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H393 - H399. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Vikstrom, T. Bohlmeyer, S. M. Factor, and L. A. Leinwand Hypertrophy, Pathology, and Molecular Markers of Cardiac Pathogenesis Circ. Res., April 20, 1998; 82(7): 773 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Corda, A. Mebazaa, M.-P. Gandolfini, C. Fitting, F. Marotte, J. Peynet, D. Charlemagne, J.-M. Cavaillon, D. Payen, L. Rappaport, et al. Trophic Effect of Human Pericardial Fluid on Adult Cardiac Myocytes : Differential Role of Fibroblast Growth Factor-2 and Factors Related to Ventricular Hypertrophy Circ. Res., November 19, 1997; 81(5): 679 - 687. [Abstract] [Full Text] |
||||
![]() |
F. Liang, J. Wu, M. Garami, and D. G. Gardner Mechanical Strain Increases Expression of the Brain Natriuretic Peptide Gene in Rat Cardiac Myocytes J. Biol. Chem., October 31, 1997; 272(44): 28050 - 28056. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stewart, M. H. Gewitz, P. K. Woolf, F. Niguidula, B. G. Fish, and G. A. Zeballos ELEVATED ARGININE VASOPRESSIN AND LOWERED ATRIAL NATRIURETIC FACTOR ASSOCIATED WITH HYPERTENSION IN COARCTATION OF THE AORTA J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 900 - 908. [Abstract] [Full Text] |
||||
![]() |
J. D. Roberts Jr, C. T. Roberts, R. C. Jones, W. M. Zapol, and K. D. Bloch Continuous Nitric Oxide Inhalation Reduces Pulmonary Arterial Structural Changes, Right Ventricular Hypertrophy, and Growth Retardation in the Hypoxic Newborn Rat Circ. Res., February 1, 1995; 76(2): 215 - 222. [Abstract] [Full Text] |
||||
![]() |
G. Bruckschlegel, S. R. Holmer, K. Jandeleit, D. Grimm, F. Muders, E. P. Kromer, G. A. J. Riegger, and H. Schunkert Blockade of the Renin-Angiotensin System in Cardiac Pressure-Overload Hypertrophy in Rats Hypertension, February 1, 1995; 25(2): 250 - 259. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |